Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332095 | 1.00 | TSHR (0.40) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL28815 | 1.00 | TSHR (0.40) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL637960 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL13176449 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL14784817 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL28895629 | 0.74 | — | — | |
| SCHEMBL454524 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL529628 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL19379407 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL454525 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658402-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2025-12-10 | — | — | EP | claimed |
| WO-2024160984-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-08 | — | — | WO | claimed |
| EP-4410419-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2024-08-07 | — | — | EP | claimed |
| US-20190292405-A1 | SLURRIES FOR CHEMICAL MECHANICAL POLISHING OF COBALT CONTAINING SUBSTRATES | FUJIMI INCORPORATED (JP) | 2019-09-26 | — | — | US | claimed |
| CN-103221033-A | Compositions for gastric delivery of active agents | YISSUM RES DEV CO | 2013-07-24 | — | — | CN | claimed |
| EP-2608771-A1 | COMPOSITIONS FOR GASTRIC DELIVERY OF ACTIVE AGENTS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2013-07-03 | — | — | EP | claimed |
| WO-2012025921-A1 | COMPOSITIONS FOR GASTRIC DELIVERY OF ACTIVE AGENTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2012-03-01 | — | — | WO | claimed |
| US-20260115215-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER | NUVAMID SA (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20260108550-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER | NUVAMID SA (CH) | 2026-04-23 | — | — | US | disclosed |
| US-20260091051-A1 | USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS | NUVAMID SA (CH) | 2026-04-02 | — | — | US | disclosed |
| US-20260063601-A1 | PLASMA METABOLOME AS A PREDICTOR OF BIOLOGICAL AGING | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4658402-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2025-12-10 | — | — | EP | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| WO-2015077414-A1 | KYNURENINE PATHWAY BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT INHIBITOR RESPONSE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| CN-103857440-A | Conjugate-based antifungal and antibacterial prodrugs | VYOME BIOSCIENCES | 2014-06-11 | — | — | CN | disclosed |
| CN-103221033-A | Compositions for gastric delivery of active agents | YISSUM RES DEV CO | 2013-07-24 | — | — | CN | disclosed |
| US-20130091932-A1 | Process and Method for Broad Spectrum Amino Acid Challenged Urinary Organic Acids | GENOVA DIAGNOSTICS, INC. | 2013-04-18 | — | — | US | disclosed |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | INSTITUTE OF CATALYSIS (CSIC) (ES) | 2012-09-13 | — | — | US | disclosed |
| WO-2010105851-A1 | PROBE COMPOUND FOR DETECTING AND ISOLATING ENZYMES AND MEANS AND METHODS USING THE SAME | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-23 | — | — | WO | disclosed |
| US-6432683-B1 | Preparation of 2-aminomuconate from 2-aminophenol by coupled enzymatic dioxygenation and dehydrogenation reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108550-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER | HBG1, KYNU, NNT | TSHR 1711/4885TP53 4321/4885EGLN1 641/4885 |
| US-20260115215-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER | HBG1, HCCS, HBG2 | TSHR 1635/4885TP53 3654/4885EGLN1 1127/4885 |
| US-20260063601-A1 | PLASMA METABOLOME AS A PREDICTOR OF BIOLOGICAL AGING | PLPBP, PLCG1, PLA2G1B | TSHR 2218/4885TP53 2672/4885EGLN1 758/4885 |
| US-20260091051-A1 | USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS | SCN1A, CHRNA1, SCN1B | TSHR 1674/4885TP53 4675/4885EGLN1 2251/4885 |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | SI, GUSB, MPI | TSHR 4023/4885TP53 1528/4885EGLN1 2017/4885 |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | TSHR 4441/4885TP53 4590/4885EGLN1 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.